WallStSmart
KALV

Kalvista Pharmaceuticals Inc

NASDAQ: KALV · HEALTHCARE · BIOTECHNOLOGY

$26.66
+0.04% today

Updated 2026-05-04

Market cap
$1.42B
P/E ratio
P/S ratio
19.29x
EPS (TTM)
$-3.94
Dividend yield
52W range
$10 – $27
Volume
2.9M

Kalvista Pharmaceuticals Inc (KALV) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+39.4%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+202.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+18.8%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+22.5%
2025-11-11
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-25$0.94+278.6%$16.46$18.95+15.1%
2025-11-11$-0.92+4.2%$10.89$13.34+22.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-01-31$-0.53$0.94+278.6%
2025-10-31$-0.96$-0.92+4.2%$59.92M
2025-07-31$-0.90$-1.12-24.4%$1.43M
2025-04-30$-0.81$-0.99-22.2%
2025-01-31$-0.87$-0.92-5.7%
2024-10-31$-0.91$-0.91+0.0%
2024-07-31$-0.91$-0.87+4.4%
2024-04-30$-0.73$-1.02-39.7%$1.21M
2024-01-31$-0.77$-0.84-9.1%
2023-10-31$-0.79$-0.80-1.3%
2023-07-31$-0.86$-0.74+14.0%
2023-04-30$-0.94$-0.77+18.1%

Frequently asked questions

Has Kalvista Pharmaceuticals Inc beaten earnings estimates?
Kalvista Pharmaceuticals Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +39.4% over the last 4 quarters.
How does KALV stock react to earnings?
KALV stock has moved an average of +18.8% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.